Platelet serotonin transporter in coeliac disease

Acta Paediatr. 1997 Jul;86(7):696-9. doi: 10.1111/j.1651-2227.1997.tb08570.x.

Abstract

We investigated a peripheral serotonergic marker, i.e. platelet tritiated imipramine (3H-IMI) binding sites, which are part of the 5-HT transporter complex similar to that present in the brain, in 20 patients affected by coeliac disease (CD), as compared with 20 healthy controls. Platelet membranes and 3H-IMI binding were carried out according to a standardized protocol. The results showed that coeliac patients had significantly lower 3H-IMI binding sites than controls. This finding would suggest the presence of a dysfunction at the level of the 5-HT transporter that might underline the psychic disturbances frequently observed in coeliac patients.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Analysis of Variance
  • Binding Sites
  • Biomarkers / analysis
  • Blood Platelets / metabolism*
  • Carrier Proteins / metabolism*
  • Celiac Disease / blood*
  • Celiac Disease / physiopathology
  • Child
  • Child, Preschool
  • Female
  • Glycoproteins / metabolism*
  • Humans
  • Imipramine / blood
  • Imipramine / metabolism
  • Male
  • Serotonin / blood
  • Serotonin / metabolism*
  • Serotonin Plasma Membrane Transport Proteins
  • Sex Factors
  • Splenectomy

Substances

  • Biomarkers
  • Carrier Proteins
  • Glycoproteins
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin
  • Imipramine